Evidence map›Paper›PMID 35980442›Full record

ArticleInternational urogynecology journal2022

International Urogynecology Consultation: Patient Reported Outcome Measures (PROs) use in the evaluation of patients with pelvic organ prolapse.

Sara Cichowski, Magdalena Emilia Grzybowska, Gabriela E Halder, Sierra Jansen, Daniela Gold, Montserrat Espuña, Swati Jha, Ahmed Al-Badr, Abdelmageed Abdelrahman, Rebecca G Rogers

Abstract read
PubMed Publisher
In one paragraph

Article in International urogynecology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Article
  14. Review
  15. Observational
  16. Surgical Systems Strengthening in Urogynecology.International urogynecology journal · 2024
    Article
  17. Measuring Pelvic Organ Prolapse: An Evolution.International urogynecology journal · 2024
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 6 countries.

Sara CichowskiOregon Health & Sciences, Portland, OR, USA. cichowss@ohsu.edu.
Magdalena Emilia GrzybowskaDepartment of Gynecology, Gynecological Oncology and Gynecological Endocrinology Medical University of Gdansk, Gdansk, Poland.
Gabriela E HalderUniversity of Texas Medical Branch, Galveston, USA.
Sierra JansenUniversity of New Mexico, Albuquerque, NM, USA.
Daniela GoldDepartment of Gynecology, Medical University Graz, Graz, Austria.
Montserrat EspuñaDepartamento Gynaecology, Hospital Clinic, Barcelona, Spain.
Swati JhaSheffield Teaching Hospitals NHS trust, Sheffield, UK.
Ahmed Al-BadrKing Fahad Medical City, Riyadh, Saudi Arabia.
Abdelmageed AbdelrahmanLiverpool Women's Hospital NHS Foundation Trust, Liverpool, UK.
Rebecca G RogersAlbany Med, Albany, NY, USA.
Gdańsk Medical University · PLHospital Clínic de Barcelona · ESKing Fahd Medical City · SALiverpool Women's Hospital · GBMedical University of Graz · ATOregon Health & Science University · USSheffield Teaching Hospitals NHS Foundation Trust · GBThe University of Texas Medical Branch at Galveston · USUniversity of New Mexico · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisPatient-reported outcome measure instruments include patient-reported outcomes (PROs) and patient-reported goals (PRGs), which allow practitioners to measure symptoms and determine outcomes of treatment that matter to patients.

methodsThis is a structured review completed by the International Urogynecology Consultation (IUC), sponsored by the International Urogynecological Association (IUGA). The aim of this working group was to evaluate and synthesize the existing evidence for PROs and PRGs in the initial clinical work-up/evaluation and research arena for patients with pelvic organ prolapse (POP).

resultsThe initial search generated 3589 non-duplicated studies. After abstract review by 4 authors, 211 full texts were assessed for eligibility by 2 writing group members, and 199 studies were reviewed in detail. Any disagreements on abstract or full-text articles were resolved by a third reviewer or during video meetings as a group. The list of POP PROs and information on PRGs was developed from these articles. Tables were generated to describe the validation of each PRO and to provide currently available, validated translations.

conclusionsAll patients presenting for POP should be evaluated for vaginal, bladder, bowel and sexual symptoms including their goals for symptom treatment. This screening can be facilitated by a validated PRO; however, most PROs provide more information than needed to provide clinical care and were designed for research purposes.

Indexed as

Pelvic Organ ProlapseFemaleHumansPatient Reported Outcome MeasuresReferral and ConsultationTranslationsPatient-reported goalsPatient-reported outcomesQuality of life measures

Identifiers

PMID35980442
OpenAlexW4292202379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.